Robert L. Ferris

55.9k total citations · 15 hit papers
556 papers, 28.7k citations indexed

About

Robert L. Ferris is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Robert L. Ferris has authored 556 papers receiving a total of 28.7k indexed citations (citations by other indexed papers that have themselves been cited), including 322 papers in Oncology, 232 papers in Otorhinolaryngology and 167 papers in Surgery. Recurrent topics in Robert L. Ferris's work include Head and Neck Cancer Studies (232 papers), Cancer Immunotherapy and Biomarkers (157 papers) and Immunotherapy and Immune Responses (93 papers). Robert L. Ferris is often cited by papers focused on Head and Neck Cancer Studies (232 papers), Cancer Immunotherapy and Biomarkers (157 papers) and Immunotherapy and Immune Responses (93 papers). Robert L. Ferris collaborates with scholars based in United States, Japan and Germany. Robert L. Ferris's co-authors include Athanassios Argiris, Michalis V. Karamouzis, William E. Gooding, David Raben, Soldano Ferrone, Jonas T. Johnson, Umamaheswar Duvvuri, Theresa L. Whiteside, Raja R. Seethala and Barbara Burtness and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert L. Ferris

540 papers receiving 28.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Head and neck cancer

2008 1.8k citations Robert L. Ferris et al. profile →
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

2011 582 citations Robert L. Ferris, Raja R. Seethala et al. profile →
Lipid accumulation and dendritic cell dysfunction in cancer

2010 565 citations Robert L. Ferris et al. profile →
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

2016 562 citations Robert L. Ferris et al. profile →
The changing therapeutic landscape of head and neck cancer

2019 535 citations Robert L. Ferris et al. profile →
Immunology and Immunotherapy of Head and Neck Cancer

2015 509 citations Robert L. Ferris Journal of Clinical Oncology profile →
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

2019 491 citations Rom S. Leidner, Robert L. Ferris et al. profile →
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

2020 452 citations Umamaheswar Duvvuri, Seungwon Kim et al. profile →
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

2017 432 citations Gulidanna Shayan, Jessica Moskovitz et al. profile →
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

2014 374 citations Umamaheswar Duvvuri, Robert L. Ferris et al. profile →
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Robert L. Ferris et al. Journal of Clinical Oncology profile →
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

2015 292 citations Umamaheswar Duvvuri, Robert L. Ferris et al. profile →
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

2018 262 citations William E. Gooding, Robert L. Ferris et al. profile →
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

2021 230 citations Umamaheswar Duvvuri, Seungwon Kim et al. profile →
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

2022 175 citations Lazar Vujanović, Robert L. Ferris et al. profile →

Peers

Countries citing papers authored by Robert L. Ferris

Since Specialization

Citations

This map shows the geographic impact of Robert L. Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Ferris more than expected).

Fields of papers citing papers by Robert L. Ferris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Ferris. The network helps show where Robert L. Ferris may publish in the future.

Co-authorship network of co-authors of Robert L. Ferris

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Ferris. A scholar is included among the top collaborators of Robert L. Ferris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Ferris. Robert L. Ferris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma 2024 ·Oral Oncology ·(unknown), (unknown), (unknown), (unknown), Mark Kubik, Seungwon Kim, Robert L. Ferris, Umamaheswar Duvvuri, Shaum Sridharan	0
2	Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes 2022 ·Clinical Cancer Research ·(unknown), Robert L. Ferris, Jing Wang	11
3	Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors 2020 ·Clinical Cancer Research ·Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John D. Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James Ohr, (unknown), Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley, Sandip Pravin Patel	63
4	Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients 2018 ·Clinical Cancer Research ·Zhuqing Liu, Elizabeth L. McMichael, Gulidanna Shayan, Jing Li, Kevin Chen, Raghvendra M. Srivastava, Larry Kane, Binfeng Lu, Robert L. Ferris	91
5	PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients 2018 ·Cancer Immunology Research ·Fernando Concha‐Benavente, Benjamin Kansy, Jessica Moskovitz, Jennifer Moy, Uma Chandran, Robert L. Ferris	123
6	Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions 2018 ·Journal of Virology ·Tatiana M. García-Bates, (unknown), Chengli Shen, Andrea Gambotto, Bernard Macatangay, Robert L. Ferris, Charles R. Rinaldo, Robbie B. Mailliard	19
7	Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine 2018 ·Clinical Cancer Research ·Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, Christopher R. Donnelly, Xiaobo Luo, Blake R. Heath, Xinyi Zhao, Emily L. Bellile, Hongxiang Hu, Hongwei Chen, Peter J. Polverini, Qianming Chen, Simon Young, Thomas E. Carey, Jacques E. Nör, Robert L. Ferris, Gregory T. Wolf, Duxin Sun, Yu L. Lei	124
8	Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients 2016 ·Clinical Cancer Research ·Sumita Trivedi, Raghvendra M. Srivastava, Fernando Concha‐Benavente, Soldano Ferrone, Tatiana M. García-Bates, Jing Li, Robert L. Ferris	103
9	CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer 2016 ·Clinical Cancer Research ·Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha‐Benavente, Sandra P. Gibson, Carly Reeder, Soldano Ferrone, Robert L. Ferris	95
10	Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice 2016 ·Cancer Immunology Research ·Andrea Sobo-Vujanovic, Lazar Vujanović, Albert B. DeLeo, Fernando Concha‐Benavente, Robert L. Ferris, Yan Lin, Nikola L. Vujanović	29
11	PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment 2014 ·Cancer Research ·Jing Li, (unknown), Yu L. Lei, Neil Gildener‐Leapman, Sumita Trivedi, Anthony R. Green, Larry Kane, Robert L. Ferris	181
12	Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients 2013 ·Clinical Cancer Research ·Rahul Srivastava, Steve Lee, Pedro A. Andrade Filho, Christopher A. Lord, Hyun-Bae Jie, (unknown), Andrés López‐Albaitero, Sandra P. Gibson, William E. Gooding, Soldano Ferrone, Robert L. Ferris	246
13	SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells 2013 ·Clinical Cancer Research ·Michael S. Leibowitz, Rahul Srivastava, Pedro A. Andrade Filho, Ann Marie Egloff, Lin Wang, Raja R. Seethala, Soldano Ferrone, Robert L. Ferris	63
14	Oncologic and Functional Outcomes of Partial Laryngeal Surgery for Intermediate‐Stage Laryngeal Cancer 2012 ·Otolaryngology ·Emiro Caicedo‐Granados, (unknown), Apostolos Christopoulos, Diana E. Cunningham, Ali Razfar, James Ohr, Dwight E. Heron, Robert L. Ferris	25
15	The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC 2012 ·Clinical Cancer Research ·Malgorzata Czystowska, William E. Gooding, Mirosław J. Szczepański, (unknown), Robert L. Ferris, Jonas T. Johnson, Theresa L. Whiteside	36
16	Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer 2011 ·Clinical Cancer Research ·Robert L. Ferris, Liqiang Xi, Raja R. Seethala, (unknown), Shaun C. Desai, Benjamin Hoch, William E. Gooding, Tony E. Godfrey	48
17	Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells 2011 ·Clinical Cancer Research ·Carmen Visús, Yangyang Wang, Antonio Lozano-León, Robert L. Ferris, Susan A. Silver, Mirosław J. Szczepański, Randall E. Brand, Cristina R. Ferrone, Theresa L. Whiteside, Soldano Ferrone, Albert B. DeLeo, Xinhui Wang	129
18	Defective NF-κB Signaling in Metastatic Head and Neck Cancer Cells Leads to Enhanced Apoptosis by Double-Stranded RNA 2011 ·Cancer Research ·Naoki Umemura, Jianzhong Zhu, Yvonne K. Mburu, Adriana Forero, Paishiun N. Hsieh, Ravikumar Muthuswamy, Paweł Kaliński, Robert L. Ferris, Saumendra N. Sarkar	29
19	Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial 2010 ·Journal of Clinical Oncology ·Francisco Civantos, Robert P. Zitsch, David E. Schuller, Amit Agrawal, Russell B. Smith, Richard W. Nason, (unknown), Christine G. Gourin, Richard J. Wong, Robert L. Ferris, Adel El Naggar, John A. Ridge, Randal C. Paniello, Kouros Owzar, Linda McCall, Douglas B. Chepeha, Wendell G. Yarbrough, Jeffrey N. Myers	264
20	Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Lisheng Ge, Dejan Baskić, Per Basse, Lazar Vujanović, (unknown), Toshie Yoneyama, (unknown), (unknown), Dragić Banković, Mirosław J. Szczepański, Jennifer L. Hunt, Ronald B. Herberman, Susanne M. Gollin, Robert L. Ferris, Theresa L. Whiteside, Eugene N. Myers, Nikola L. Vujanović	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact